SURESH NAIR: Open Payments
NPI 1629002787 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,636 in 125 payments from 27 companies in 2025. Trend: 2023 $3,211 · 2024 $3,993 · 2025 $2,636
Food & beverage: $2,636
| Company | Payments | Amount |
|---|---|---|
| MIMEDX Group, Inc. | 6 | $500 |
| ABBVIE INC. | 20 | $331 |
| PFIZER INC. | 21 | $286 |
| Vanda Pharmaceuticals Inc. | 7 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $185 |
| Otsuka America Pharmaceutical, Inc. | 9 | $142 |
| Novartis Pharmaceuticals Corporation | 5 | $124 |
| Medtronic, Inc. | 3 | $106 |
| UCB, Inc. | 5 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $87 |
Products named: NURTEC ODT, VRAYLAR, CAPLYTA, REXULTI, HETLIOZ, LEQVIO, Briviact, Kerendia.
Industry payments across KY — which companies pay providers there.
